// App-Quantinova.ai

PO0801 : Severe Rhabdomyolysis in the Time of Coronavirus

Researchers

Presenter

  • Alvarez Torres Sergio�E.

Principal Investigators

  • Collazo-Maldonado RobertoL

Medical Centers

  • Methodist Dallas Medical Center Dallas Texas United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Dyspnea

  • Severe COVID-19 pneumonia

  • Rhabdomyolysis

  • Dyslipidemia

  • Influenza

  • Coronavirus disease

Biomarkers

  • Creatinine

  • White Blood Cell

  • Red Blood Cells

Drug/Treatment

  • Hydroxychloroquine

  • Azithromycin

  • ceftriaxone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved